Balance Sheet cbdMD, Inc.

Equities

YCBD

US12482W4087

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 11:49:01 2026-01-21 am EST			5-day change	1st Jan Change
0.8040 ^USD	-3.25%		-24.91%	-40.48%

Jan. 14	cbdMD announces strategic acquisition of Bluebird Botanicals	RE
Jan. 13	CbdMD, Inc. acquired assets of Gaia Botanicals, LLC for $1 million.	CI

547e7667.x148YkAaP32TAEOhGRCBUtgSVeeooyapouNU49cdBS0.rGZPUgtQTRzjRRP3KSmwMK9LZpXe6nSc0Kkxs6NLbHmiEXYxeVhnE8U0LA

Published financial data: CBDMD, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	44.48M	35.4M	24.16M	19.48M	19.19M
Total Revenues	44.48M	35.4M	24.16M	19.48M	19.19M
Cost of Goods Sold, Total	14.5M	13.07M	9.18M	7.49M	7.22M
Gross Profit	29.99M	22.34M	14.98M	12M	11.97M
Selling General & Admin Expenses, Total	44.92M	39.65M	17.36M	13.27M	11.99M
R&D Expenses	1.42M	-	173K	39.02K	33.86K
Depreciation & Amortization - (IS)	1.02M	-	404K	452K	361K
Amortization of Goodwill and Intangible Assets - (IS)	-	-	1.4M	698K	765K
Other Operating Expenses	2.24M	-	4.91M	857K	979K
Other Operating Expenses, Total	49.6M	39.65M	24.25M	15.31M	14.13M
Operating Income	-19.62M	-17.31M	-9.27M	-3.32M	-2.16M
Interest Expense, Total	-28.93K	-	-	-29.51K	-
Interest And Investment Income	-	-	63.7K	-	34.31K
Net Interest Expenses	-28.93K	-	63.7K	-29.51K	34.31K
Other Non Operating Income (Expenses)	29.48K	255K	-	-	-
EBT, Excl. Unusual Items	-19.62M	-17.06M	-9.2M	-3.34M	-2.13M
Restructuring Charges	-	-602K	-	-	-
Impairment of Goodwill	-	-60.96M	-	-	-
Gain (Loss) On Sale Of Investments	547K	-33.35K	-700K	-	-
Gain (Loss) On Sale Of Assets	-	88.77K	-	-	-
Asset Writedown	-	-	-13.22M	-	-
Other Unusual Items	-5.22M	8.47M	186K	-355K	87.38K
EBT, Incl. Unusual Items	-24.29M	-70.08M	-22.94M	-3.7M	-2.04M
Income Tax Expense	-895K	-	-	-	-
Earnings From Continuing Operations	-23.39M	-70.08M	-22.94M	-3.7M	-2.04M
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-23.39M	-70.08M	-22.94M	-3.7M	-2.04M
Minority Interest	-	-	-	-	-
Net Income - (IS)	-23.39M	-70.08M	-22.94M	-3.7M	-2.04M
Preferred Dividend and Other Adjustments	2.55M	4M	4M	4M	2.33M
Net Income to Common Incl Extra Items	-25.95M	-74.09M	-26.94M	-7.7M	-4.38M
Net Income to Common Excl. Extra Items	-25.95M	-74.09M	-26.94M	-7.7M	-4.38M
Per Share Items
Net EPS - Basic	-170.04	-446.37	-106.57	-14.29	-1.09
Basic EPS - Continuing Operations	-170.04	-446.37	-106.57	-14.29	-1.09
Basic Weighted Average Shares Outstanding	153K	166K	253K	539K	4.02M
Net EPS - Diluted	-170.04	-446.4	-106.57	-14.32	-1.09
Diluted EPS - Continuing Operations	-170.04	-446.4	-106.57	-14.32	-1.09
Diluted Weighted Average Shares Outstanding	153K	166K	253K	539K	4.02M
Normalized Basic EPS	-80.34	-64.22	-22.76	-3.88	-0.33
Normalized Diluted EPS	-80.34	-64.22	-22.76	-3.88	-0.33
Payout Ratio	-10.92	-5.71	-15.99	-	-
Supplemental Items
EBITDA	-18.6M	-15.48M	-7.47M	-2.17M	-1.04M
EBITA	-19.57M	-16.43M	-7.87M	-2.62M	-1.4M
EBIT	-19.62M	-17.31M	-9.27M	-3.32M	-2.16M
EBITDAR	-17.05M	-14.09M	-6.14M	512K	352K
Total Revenues (As Reported)	44.48M	35.4M	24.16M	19.48M	19.19M
Effective Tax Rate - (Ratio)	3.68	-	-	-	-
Deferred Domestic Taxes	-895K	-	-	-	-
Total Deferred Taxes	-895K	-	-	-	-
Normalized Net Income	-12.26M	-10.66M	-5.75M	-2.09M	-1.33M
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Marketing Expenses	17.9M	15.36M	5.98M	4.18M	4.43M
Selling and Marketing Expenses	19.64M	-	6.95M	4.18M	4.43M
General and Administrative Expenses	4.36M	-	2.62M	2.17M	1.78M
Research And Development Expense From Footnotes	1.42M	-	173K	39.02K	33.86K
Net Rental Expense, Total	1.55M	1.39M	1.33M	2.68M	1.39M
Imputed Operating Lease Interest Expense	48.54K	-	-	255K	-
Imputed Operating Lease Depreciation	1.5M	-	-	2.42M	-
Stock-Based Comp., SG&A Exp. (Total)	3.15M	-	349K	43.69K	13.6K
Stock-Based Comp., Other (Total)	97.72K	-	885K	-	87.18K
Total Stock-Based Compensation	3.25M	-	1.23M	43.69K	101K

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	26.41M	6.72M	1.8M	2.45M	2.26M
Short Term Investments	1.03M	1M	-	-	-
Total Cash And Short Term Investments	27.44M	7.72M	1.8M	2.45M	2.26M
Accounts Receivable, Total	1.11M	1.45M	1.22M	984K	1.04M
Other Receivables	-	-	-	-	-
Total Receivables	1.11M	1.45M	1.22M	984K	1.04M
Inventory	5.57M	4.77M	4.24M	2.52M	2.95M
Prepaid Expenses	1.15M	702K	750K	407K	277K
Other Current Assets, Total	1.22M	1.37M	70.06K	21.75K	25.23K
Total Current Assets	36.5M	16.01M	8.07M	6.39M	6.55M
Gross Property Plant And Equipment	10.04M	6.36M	5.53M	2.44M	3.25M
Accumulated Depreciation	-1.86M	-1.05M	-1.46M	-1.9M	-2.27M
Net Property Plant And Equipment	8.18M	5.3M	4.07M	540K	981K
Long-term Investments	-	1.4M	700K	700K	700K
Goodwill	56.67M	-	-	-	-
Other Intangibles, Total	23M	17.83M	3.22M	2.89M	2.12M
Other Long-Term Assets, Total	530K	245K	139K	62.71K	62.71K
Total Assets	125M	40.79M	16.2M	10.58M	10.42M
Liabilities
Accounts Payable, Total	2.98M	2.04M	1.91M	1.54M	1.17M
Accrued Expenses, Total	2.73M	2.06M	1.48M	633K	736K
Short-term Borrowings	59.47K	9.61K	2.49K	1.17M	-
Current Portion of Long-Term Debt	-	-	-	-	-
Current Portion of Leases	1.15M	1.18M	1.28M	98.7K	778K
Unearned Revenue Current, Total	-	-	-	503K	506K
Other Current Liabilities	-	-	-	4.67M	-
Total Current Liabilities	6.92M	5.29M	4.67M	8.62M	3.19M
Long-Term Debt	-	3K	-	-	-
Long-Term Leases	4.86M	3.68M	2.4M	-	-
Deferred Tax Liability Non Current	-	-	-	-	-
Other Non Current Liabilities	9.96M	398K	90.37K	-	-
Total Liabilities	21.74M	9.37M	7.16M	8.62M	3.19M
Preferred Stock Convertible	5K	5K	5K	5K	1.7K
Total Preferred Equity	5K	5K	5K	5K	1.7K
Common Stock, Total	57.78K	60.67K	2.96K	3.94K	8.92K
Additional Paid In Capital	176M	179M	183M	184M	187M
Retained Earnings	-73.34M	-147M	-174M	-182M	-179M
Comprehensive Income and Other	-	-	-	-7.19K	-
Total Common Equity	103M	31.42M	9.03M	1.96M	7.22M
Total Equity	103M	31.42M	9.03M	1.96M	7.23M
Total Liabilities And Equity	125M	40.79M	16.2M	10.58M	10.42M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	161K	169K	370K	692K	9.42M
ECS Total Common Shares Outstanding	161K	169K	370K	492K	8.92M
Book Value / Share	642.56	186.45	24.39	3.98	0.81
Tangible Book Value	23.46M	13.58M	5.81M	-931K	5.1M
Tangible Book Value Per Share	146.17	80.61	15.69	-1.89	0.57
Total Debt	6.07M	4.87M	3.68M	1.27M	778K
Net Debt	-21.38M	-2.85M	1.89M	-1.18M	-1.48M
Debt Equivalent Oper. Leases	12.38M	11.13M	10.63M	21.42M	11.11M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	3.36M	3.2M	2.78M	1.53M	1.58M
Inventories - Others	1.73M	1.21M	1.4M	830K	1.2M
Machinery, Total	3.55M	1.39M	1.69M	1.87M	2.05M
Full Time Employees	154	90	52	42	42
Accumulated Allowance for Doubtful Accounts (Supple)	3.63K	36.98K	42.18K	346K	600K

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	-23.39M	-70.08M	-22.94M	-3.7M	-2.04M
Depreciation & Amortization - CF	2.21M	2.09M	1.53M	1.12M	1.03M
Amortization of Goodwill and Intangible Assets - (CF)	48.48K	884K	1.4M	698K	765K
Depreciation & Amortization, Total	2.25M	2.97M	2.93M	1.82M	1.8M
(Gain) Loss From Sale Of Asset	-	-322K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	325K	941K	700K	-	-
Asset Writedown & Restructuring Costs	-	60.96M	13.22M	-	-
Stock-Based Compensation (CF)	3.02M	929K	343K	16.9K	101K
Provision and Write-off of Bad Debts	-	-	-	-	383K
Net Cash From Discontinued Operations	436K	9.59K	1.38K	-	-
Other Operating Activities, Total	6.09M	-7.6M	875K	1.97M	279K
Change In Accounts Receivable	-184K	65.54K	278K	232K	-440K
Change In Inventories	-1.27M	-72.13K	356K	790K	-789K
Change In Accounts Payable	-104K	-1.81M	-1.29M	-1.12M	-262K
Change in Unearned Revenues	3.72K	203K	203K	318K	3.1K
Change In Deferred Taxes	-895K	-	-	-	-
Change in Other Net Operating Assets	-372K	-1.16M	1.02M	-679K	-482K
Cash from Operations	-14.09M	-14.97M	-4.3M	-353K	-1.45M
Capital Expenditure	-342K	-689K	-298K	-190K	-184K
Cash Acquisitions	-2M	-	-	-	-
Sale (Purchase) of Intangible assets	-	-	-	-100K	-
Investment in Marketable and Equity Securities, Total	-210K	-	1M	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-2.55M	-689K	702K	-290K	-184K
Short Term Debt Issued, Total	-	-	-	1.25M	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	-	-	1.25M	-
Short Term Debt Repaid, Total	-152K	-33.36K	-133K	-	-
Total Debt Repaid	-152K	-33.36K	-133K	-	-
Issuance of Common Stock	-	-	2.48M	50K	-
Issuance of Preferred Stock	30.94M	-	-	-	1.45M
Preferred Dividends Paid	-2.55M	-4M	-3.67M	-	-
Common & Preferred Stock Dividends Paid	-2.55M	-4M	-3.67M	-	-
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	28.23M	-4.04M	-1.32M	1.3M	1.45M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	11.59M	-19.69M	-4.92M	655K	-191K
Supplemental Items
Cash Interest Paid	28.93K	2.36K	6.4K	74.64K	-
Levered Free Cash Flow	-7.48M	-9.38M	-616K	5.78M	-4.93M
Unlevered Free Cash Flow	-7.46M	-9.38M	-616K	5.79M	-4.93M
Change In Net Working Capital	360K	843K	-1.31M	-6.29M	5.29M
Net Debt Issued / Repaid	-152K	-33.36K	-133K	1.25M	-

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	-10.4	-13.06	-20.33	-15.48	-12.87
Return on Total Capital	-12.44	-14.87	-23.64	-25.99	-24.05
Return On Equity %	-25.66	-104.16	-113.4	-67.31	-44.42
Return on Common Equity	-28.47	-110.12	-133.22	-140.27	-95.3
Margin Analysis
Gross Profit Margin %	67.41	63.09	62.01	61.57	62.37
SG&A Margin	100.99	111.99	71.89	68.09	62.49
EBITDA Margin %	-41.81	-43.72	-30.92	-11.12	-5.4
EBITA Margin %	-43.99	-46.4	-32.59	-13.44	-7.28
EBIT Margin %	-44.1	-48.9	-38.37	-17.02	-11.27
Income From Continuing Operations Margin %	-52.6	-197.96	-94.96	-18.99	-10.63
Net Income Margin %	-52.6	-197.96	-94.96	-18.99	-10.63
Net Avail. For Common Margin %	-58.34	-209.26	-111.53	-39.54	-22.8
Normalized Net Income Margin	-27.56	-30.11	-23.82	-10.73	-6.93
Levered Free Cash Flow Margin	-16.81	-26.5	-2.55	29.65	-25.66
Unlevered Free Cash Flow Margin	-16.77	-26.5	-2.55	29.74	-25.66
Asset Turnover
Asset Turnover	0.38	0.43	0.85	1.46	1.83
Fixed Assets Turnover	4.88	5.25	5.16	8.46	25.23
Receivables Turnover (Average Receivables)	43.93	27.65	18.14	17.71	18.96
Inventory Turnover (Average Inventory)	2.77	2.53	2.04	2.22	2.64
Short Term Liquidity
Current Ratio	5.28	3.03	1.73	0.74	2.05
Quick Ratio	4.13	1.73	0.65	0.4	1.03
Operating Cash Flow to Current Liabilities	-2.04	-2.83	-0.92	-0.04	-0.45
Days Sales Outstanding (Average Receivables)	8.31	13.2	20.13	20.66	19.26
Days Outstanding Inventory (Average Inventory)	131.76	144.43	179.03	165.23	138.25
Average Days Payable Outstanding	70.1	74.66	83.23	109.24	64.81
Cash Conversion Cycle (Average Days)	69.97	82.98	115.93	76.66	92.7
Long Term Solvency
Total Debt/Equity	5.88	15.5	40.78	64.68	10.77
Total Debt / Total Capital	5.56	13.42	28.97	39.28	9.72
LT Debt/Equity	4.71	11.72	26.61	-	-
Long-Term Debt / Total Capital	4.45	10.15	18.9	-	-
Total Liabilities / Total Assets	17.41	22.96	44.24	81.44	30.65
EBIT / Interest Expense	-678.05	-	-	-112.36	-
EBITDA / Interest Expense	-589.4	-	-	17.36	-
(EBITDA - Capex) / Interest Expense	-601.23	-	-	10.92	-
Total Debt / EBITDA	-0.36	-0.35	-0.6	2.48	2.21
Net Debt / EBITDA	1.25	0.2	-0.31	-2.31	-4.21
Total Debt / (EBITDA - Capex)	-0.35	-0.33	-0.57	3.94	4.63
Net Debt / (EBITDA - Capex)	1.23	0.19	-0.29	-3.67	-8.82
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.2	-20.41	-31.77	-19.35	-1.5
Gross Profit, 1 Yr. Growth %	13.72	-25.51	-32.95	-19.91	-0.23
EBITDA, 1 Yr. Growth %	10.3	-16.78	-51.75	-71	-52.14
EBITA, 1 Yr. Growth %	11.29	-16.26	-52.08	-66.74	-46.62
EBIT, 1 Yr. Growth %	11.57	-11.75	-46.46	-64.23	-34.77
Earnings From Cont. Operations, 1 Yr. Growth %	-284.92	199.57	-67.27	-83.87	-44.84
Net Income, 1 Yr. Growth %	-285.64	199.57	-67.27	-83.87	-44.84
Normalized Net Income, 1 Yr. Growth %	11.82	-13.05	-46.03	-63.66	-36.37
Diluted EPS Before Extra, 1 Yr. Growth %	-269.72	162.52	-76.13	-86.56	-92.39
Accounts Receivable, 1 Yr. Growth %	22.15	30.04	-16.01	-19.09	5.79
Inventory, 1 Yr. Growth %	13.94	-14.46	-11.15	-40.41	16.75
Net Property, Plant and Equip., 1 Yr. Growth %	-18.52	-35.17	-23.27	-86.72	81.7
Total Assets, 1 Yr. Growth %	12.67	-67.34	-60.3	-34.66	-1.53
Tangible Book Value, 1 Yr. Growth %	715.64	-42.1	-57.25	-116.03	-647.69
Common Equity, 1 Yr. Growth %	30.25	-69.54	-71.27	-78.3	268.89
Cash From Operations, 1 Yr. Growth %	32.15	6.2	-71.26	-91.8	311.68
Capital Expenditures, 1 Yr. Growth %	-74.09	101.36	-56.79	-36.14	-3.08
Levered Free Cash Flow, 1 Yr. Growth %	66.79	25.42	-92.54	-484.89	-185.26
Unlevered Free Cash Flow, 1 Yr. Growth %	66.39	25.72	-92.54	-486.12	-184.99
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	37.14	-8.06	-26.31	-25.82	-10.87
Gross Profit, 2 Yr. CAGR %	43.73	-7.96	-29.33	-26.72	-10.61
EBITDA, 2 Yr. CAGR %	14.88	-4.19	-36.63	-62.59	-62.75
EBITA, 2 Yr. CAGR %	17.05	-3.34	-36.65	-60.08	-57.87
EBIT, 2 Yr. CAGR %	16.88	-0.77	-31.26	-56.24	-51.7
Earnings From Cont. Operations, 2 Yr. CAGR %	-28.24	135.36	-0.98	-77.02	-70.17
Net Income, 2 Yr. CAGR %	-31.89	135.82	-0.98	-77.02	-70.17
Normalized Net Income, 2 Yr. CAGR %	17.18	-1.4	-31.5	-55.71	-51.92
Diluted EPS Before Extra, 2 Yr. CAGR %	-56.87	111.08	-20.83	-82.09	-89.9
Accounts Receivable, 2 Yr. CAGR %	-11.63	26.03	4.51	-17.56	-7.48
Inventory, 2 Yr. CAGR %	3.48	-1.28	-12.82	-27.24	-16.59
Net Property, Plant and Equip., 2 Yr. CAGR %	118.31	-27.32	-29.47	-68.08	-50.88
Total Assets, 2 Yr. CAGR %	14.95	-39.34	-63.99	-49.07	-19.79
Tangible Book Value, 2 Yr. CAGR %	-22.14	117.32	-50.25	-73.82	-6.29
Common Equity, 2 Yr. CAGR %	65.61	-37.01	-70.42	-75.03	-10.54
Cash From Operations, 2 Yr. CAGR %	-4.27	18.47	-44.75	-84.65	-41.9
Capital Expenditures, 2 Yr. CAGR %	-46.58	-27.77	-6.73	-47.47	-21.33
Levered Free Cash Flow, 2 Yr. CAGR %	-9.78	44.63	-71.31	-16.35	81.15
Unlevered Free Cash Flow, 2 Yr. CAGR %	-9.89	44.63	-71.27	-16.22	81.15
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	359.29	14.39	-16.76	-24.06	-18.46
Gross Profit, 3 Yr. CAGR %	338.73	15.45	-17.18	-26.32	-18.78
EBITDA, 3 Yr. CAGR %	126.31	3.17	-23.77	-51.17	-59.39
EBITA, 3 Yr. CAGR %	129.88	4.78	-23.5	-48.9	-56.02
EBIT, 3 Yr. CAGR %	121.83	6.43	-19.22	-44.71	-50.01
Earnings From Cont. Operations, 3 Yr. CAGR %	135.24	15.55	21.94	-45.92	-69.23
Net Income, 3 Yr. CAGR %	284.34	11.6	22.1	-45.92	-69.23
Normalized Net Income, 3 Yr. CAGR %	121.83	6.09	-19.34	-44.55	-50.03
Diluted EPS Before Extra, 3 Yr. CAGR %	26.72	-21.26	2.08	-56.17	-86.54
Accounts Receivable, 3 Yr. CAGR %	-15.51	0.51	10.09	-4.04	-10.42
Inventory, 3 Yr. CAGR %	-	-2.89	-4.69	-23.2	-14.82
Net Property, Plant and Equip., 3 Yr. CAGR %	1.11K	45.65	-25.99	-59.58	-43.01
Total Assets, 3 Yr. CAGR %	102.6	-24.43	-47.33	-56.08	-36.55
Tangible Book Value, 3 Yr. CAGR %	24.37	-29.46	26.39	-65.89	-27.86
Common Equity, 3 Yr. CAGR %	101.5	-5.81	-51.51	-73.32	-38.74
Cash From Operations, 3 Yr. CAGR %	36.24	-0.9	-26.11	-70.75	-54.05
Capital Expenditures, 3 Yr. CAGR %	143.95	-16.87	-39.14	-17.79	-35.57
Levered Free Cash Flow, 3 Yr. CAGR %	-	0.69	-48.41	-8.25	-15.82
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	0.69	-48.41	-8.08	-15.82
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	120.91	-3.8	-14.45
Gross Profit, 5 Yr. CAGR %	-	-	111.36	-3.74	-14.61
EBITDA, 5 Yr. CAGR %	-	-	36.01	-31.24	-42.76
EBITA, 5 Yr. CAGR %	-	-	37.34	-28.77	-39.74
EBIT, 5 Yr. CAGR %	-	-	38.83	-25.41	-34.24
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	66.42	-39.44	-30.57
Net Income, 5 Yr. CAGR %	-	-	123.42	-40.69	-30.52
Normalized Net Income, 5 Yr. CAGR %	-	-	38.64	-25.2	-34.42
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	4.99	-56.45	-59.53
Accounts Receivable, 5 Yr. CAGR %	-	-	-8.01	-7.15	2.69
Inventory, 5 Yr. CAGR %	-	-	-	-13.48	-9.64
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	288.33	-20.64	-37.19
Total Assets, 5 Yr. CAGR %	-	-	1.52	-35.46	-37.68
Tangible Book Value, 5 Yr. CAGR %	-	-	-13.79	-52.55	12.13
Common Equity, 5 Yr. CAGR %	-	-	-6.46	-44.62	-38.05
Cash From Operations, 5 Yr. CAGR %	-	-	-5.05	-53	-32.88
Capital Expenditures, 5 Yr. CAGR %	-	-	66.07	-30.81	-32.56
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-8.87	1.89
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-8.81	1.89